AI assistant
Sending…
RESMED INC — Director's Dealing 2024
Oct 15, 2024
30071_dirs_2024-10-15_14df38f4-0a0e-48c4-b0f5-a78c5b20a2b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-10-11
Reporting Person: Ghoshal Kaushik (Chief Commercial Officer, SaaS)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-11 | ResMed Common Stock | M | 4260 | $101.64 | Acquired | 26048 | Direct |
| 2024-10-11 | ResMed Common Stock | S | 4260 | $238.48 | Disposed | 21788 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-11 | ResMed Common Stock Options | $101.64 | M | 4260 | Disposed | 2025-11-14 | ResMed Common Stock (4260) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted April 29, 2024.
F2: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29